Home/Filings/4/0000950170-25-062886
4//SEC Filing

Gao Hanlin 4

Accession 0000950170-25-062886

CIK 0001674930other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:53 PM ET

Size

4.9 KB

Accession

0000950170-25-062886

Insider Transaction Report

Form 4
Period: 2025-04-30
Gao Hanlin
Chief Scientific Officer
Transactions
  • Tax Payment

    Common Stock

    2025-04-30$17.35/sh79$1,371963,074 total
Footnotes (1)
  • [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021.

Documents

1 file

Issuer

Fulgent Genetics, Inc.

CIK 0001674930

Entity typeother

Related Parties

1
  • filerCIK 0001684532

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:53 PM ET
Size
4.9 KB